PAIN TREATMENT SYSTEM
Medical Professionals Only

NSAID drugs constitute the 15th most common cause of death in the United States. Topical NSAID’S and intra-articular steroid injections offer no meaningful pain relief beyond the first month. More than 70 percent of patients who took painkillers such as ibuprofen for more than three months suffered damage to their small intestines. COX-2 inhibitors can raise the risk of heart death.

Photomedicine is the application of red and near infrared laser therapy over compromised areas such injuries, arthritic joints, nerves and the stellate ganglion to create a neural blockade. The light suppresses axonal transport leading to a reduction of pain and inflammation without sensation or side effects. Photomedicine (low level laser therapy) provides medical practitioners and physical therapists with the ability to provide their patients with an improved level of non-invasive, drug free pain relief and tissue regeneration. Photomedicine has emerged from the convergence of technology and clinical evidence. It allows Practitioners a low cost and safe alternative to pharmaceuticals. Laser therapy provides a pharmaceutical-free form of sustainable pain relief.

CLINICAL STUDIES

THE EFFECT OF GALLIUM ARSENIDE ALUMINUM LASER THERAPY IN THE MANAGEMENT OF CERVICAL MYOFASCIAL PAIN
The efficacy of low-level laser therapy (LLLT) in myofascial pain syndrome (MPS) seems controversial. A prospective, double-blind, randomized controlled trial was conducted in patients with chronic MPS in the neck to evaluate the effects of low-level 830-nm gallium arsenide aluminum (Ga–As–Al) laser therapy. The study group consisted of 64 MPS patients.

RETROSPECTIVE STUDY OF ADJUNCTIVE DIODE LASER THERAPY FOR PAIN ATTENTUATION IN 662 PATIENTS
Subjects were 1087 patients treated between April 1992 to august 1995. The efficacy rating immediately after treatment was 46.8% in men and 47% in women, rising to 73.3% in men and 76.8% in women at time of survey (1996). Conclusion: Infrared Diode Low Level Laser Therapy (Photomedicine) is considered safe, effective and side effect free making an ideal adjunctive therapeutic modality for intractable chronic pain.

THE EFFECT OF INFRA-RED LASER IRRADIATION ON THE DURATION AND SEVERITY OF POST-OPERATIVE PAIN: A DOUBLE BLIND STUDY
There was a significant difference in the number doses of narcotic analgesic required between the groups. No patient in the treatment group required narcotic analgesia after 24 hours. Similarly the requirement for oral analgesia was reduced in the treated group. Control patients assessed their overall pain as moderate to severe compared with mild to moderate in the treated group.

THE EFFECT OF LASER THERAPY ON CHRONIC NECK PAIN: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
A randomized, double-blind, placebo-controlled study of low-level laser therapy (LLLT) in 90 subjects with chronic neck pain. Treatment was efficacious in providing pain relief for patients with chronic neck pain over a period of 3 months.

A DOUBLE BLIND STUDY PLACEBO CONTROLLED INVESTIGATION OF THE HYPOALGESIC EFFECTS OF LOW INTENSITY LASER IRRADIATION OF THE CERVICAL NERVE ROOTS USING EXPERIMENTAL ISCHAEMIC PAIN
Basim Mokhtar,D.Walker,G David Baxter,A Jean Bell & Jim M Allen

THE EFFECT OF LOW LEVEL LASER IRRADIATION OF IPSILATERAL ERB'S POINT UPON TOURNIQUET- INDUCED ISCHAEMIC PAIN: A SINGLE BLIND STUDY
B Mokhtar, G D Baxter, J M Allen & A J Bell

LOW LEVEL LASER THERAPY (LLLT) OF TENDINITIS AND MYOFASCIAL PAINS. A RANDOMISED, DOUBLE BLIND CONTROLLED STUDY
Mimmi Logdberg-Anderssont - Akersberga Health Care Centre

DIODE LASER IN CERVICAL MYOFASCIAL PAIN: A DOUBLE BLIND STUDY VERSUS PLACEBO
F. Ceccherelli, L.Atalfini, G Lo Castro, A Avila, F Ambrosio and G P Giron

PHYSIOLOGICAL RESPONSES IN CHRONIC PAIN PATIENTS LLLT PROTOCOL
Scott D Fender and David Diffee - Pain Research Group

LLLT (LOW REACTIVE LEVEL LASER THERAPY) - A CLINICAL STUDY: RELATIONSHIP BETWEEN PAIN ATTENUATION AND THE SEROTONERGIC MECHANISM
Tohru Mizokami, Kazuya Aoki*, Satoshi Iwabuchi*, Keiichirou Kasai*, Yasuyuki Yamazaki*, Takatoshi Sakurai*, Kanji Samejima* and Nobou Yoshii*